ATN Innovation Summit sessions are now on demand.
Every keynote, panel, and fireside chat are now streaming in the video library.
Novo Nordisk's CEO says the company’s blockbuster obesity drugs could ultimately pull it into increasingly buzzy areas of healthcare, from longevity research to aesthetic medicine.
Sign Up to Our Newsletter
